New implant could curb heavy drinking for months
NCT ID NCT07433413
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tests a naltrexone implant placed under the skin to help people with moderate to severe alcohol use disorder drink less. About 240 adults will receive either the implant or a placebo, plus counseling. Researchers will track heavy drinking days over 24 weeks to see if the implant works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- naltrexone hydrochloride implant
- What this could lead to
- If successful, this implant could provide a long-lasting treatment option to help people with alcohol use disorder reduce heavy drinking days.
- What could go wrong
- This is a Phase 3 trial, but it hasn't started recruiting yet. The implant may not work better than placebo, and side effects like nausea or implant site reactions are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Zapping the brain to fight alcoholism: a new hope?
- Rewiring the brain to fight alcohol cravings?
- Can cash rewards and a breathalyzer app help people stay sober?
- Could a brain hormone curb alcohol cravings and lift depression at the same time?
- Mindfulness may help tame alcohol cravings by reconnecting body and mind